Dr. Oliver M. Dovey is a distinguished leader with over two decades of  experience in genetic engineering and extensive expertise in mammalian genomics. He has dedicated his career to advancing biotechnology through innovation, directing substantial, interdisciplinary teams encompassing Next-Generation Sequencing (NGS), Synthetic/Engineering Biology, Technology Development, Cellular Engineering, and High Throughput Functional Genomics. His work directly addresses emerging technologies in Cell and Gene Therapy and Dr. Dovey's strategic vision has defined R&D pathways for both clinical and non-clinical asset development, focusing on building scalable platforms and leading the development of bit.bio’s SynBio technology stack to deliver RUO and preclinical/clinical cell assets.